MedTrace Logo

Evaluation of Cardiovascular Risk Among the Participants of the ESC Congress 2026

NCT07778784 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1300

Last updated 2026-08-21

No results posted yet for this study

Summary

The European Society of Cardiology (ESC) is dedicated to promoting cardiovascular (CV) health and minimizing the occurrence of cardiovascular diseases throughout Europe. As a founding member of the European Alliance for Cardiovascular Health (EACH), the ESC is advocating for European and National Cardiovascular Health Plans which would include a cardiovascular and diabetes health check as part of a screening process for citizens.

In line with this call for public health diagnosis of CV health, the ESC is committed to raising awareness on the need for actions and proposes to offer complimentary tests to delegates at ESC Congress 2026 from 28-31 August 2026 in Munich, Germany.

The primary objective of the study is to screen the CV risk among the ESC Annual Congress 2026 attendees with a focus on healthcare professionals (HCP) and to stratify by primary or secondary prevention.

Conditions

  • Cardiovascular Risks

Interventions

BIOLOGICAL

Capillary blood draw

Capillary blood draw to assess several cardiovascular risk markers

BEHAVIORAL

Questionnaire and Physical Exam

Waist circumference and blood pressure measurements

BIOLOGICAL

Urine sample

Urine sample

BEHAVIORAL

Questionnaire and Physical Exam

Questionnaire about lifestyle habits and medical history

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-28
Primary Completion
2026-08-31
Completion
2026-08-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07778784 on ClinicalTrials.gov